Publication Ethics & Integrity Policy

Upholding the highest standards of scholarly publishing in line with COPE, ICMJE, and global best practices.

CEPIENTA® requires all stakeholders — authors, editors, reviewers, and publishers — to adhere to ethical principles ensuring integrity, objectivity, and transparency throughout the publication process.

01

Commitment to Ethical Publishing

CEPIENTA® is committed to maintaining the highest standards of publication ethics, research integrity, and transparency in scholarly communication. Our journals adhere to internationally recognized ethical standards established by organizations such as COPE, ICMJE, and global editorial best-practice frameworks adopted by leading publishers.

Publication in peer-reviewed journals represents a fundamental component of the scientific record and contributes to the advancement of knowledge. Therefore, CEPIENTA® requires all stakeholders — including authors, editors, reviewers, and publishers — to adhere to ethical principles ensuring integrity, objectivity, and transparency throughout the publication process.

02

Responsibilities of the Publisher

CEPIENTA®, as the publisher, ensures the integrity of the scholarly record and supports editors and reviewers in maintaining rigorous standards.

2.1 Integrity of the Scholarly Record

CEPIENTA® safeguards the reliability and permanence of published research through editorial oversight, ethical screening, and appropriate correction mechanisms.

2.2 Editorial Independence

Editorial decisions are made independently by journal editors, without influence from commercial interests such as advertising, sponsorship, or publication fees.

2.3 Ethical Oversight

The publisher supports editors in identifying and addressing issues related to:

  • Plagiarism
  • Data fabrication or falsification
  • Image manipulation
  • Duplicate publication
  • Ethical approval violations

Appropriate actions — including corrections, expressions of concern, or retractions — will be taken when ethical violations are confirmed.

2.4 Support for Editors and Reviewers

CEPIENTA® provides editorial systems, plagiarism detection tools, and ethical guidance to ensure responsible peer review and editorial decision-making.

2.5 Education and Transparency

The publisher promotes education on research integrity and publication ethics for authors, reviewers, and editors.

03

Responsibilities of Editors

Editors play a central role in maintaining the scientific integrity of the journals published by CEPIENTA®.

3.1 Editorial Decision Making

Editors are responsible for deciding which manuscripts are suitable for publication based solely on:

  • Scientific merit
  • Relevance to the journal scope
  • Methodological validity
  • Ethical compliance

3.2 Fair and Unbiased Evaluation

Editors evaluate manuscripts without discrimination regarding race, gender, institutional affiliation, nationality, or religious and political beliefs.

3.3 Confidentiality

Editors must maintain strict confidentiality regarding submitted manuscripts and peer review communications.

3.4 Peer Review Integrity

Editors ensure that manuscripts undergo fair, unbiased, and timely peer review, typically by at least two independent experts in the relevant field.

3.5 Conflict of Interest Management

Editors must recuse themselves from handling manuscripts where conflicts of interest exist (e.g., institutional, financial, or collaborative relationships).

3.6 Correction of the Published Record

Editors are responsible for issuing corrections or errata when errors are identified, publishing retractions when findings are unreliable or unethical, and investigating suspected misconduct in collaboration with the publisher.

04

Responsibilities of Authors

Authors submitting manuscripts to CEPIENTA® journals must adhere to high standards of research and publication ethics.

4.1 Originality and Plagiarism

Authors must submit original work and appropriately cite all sources used. Plagiarism in any form — including copying, paraphrasing without attribution, or presenting others' research as one's own — is considered unethical.

4.2 Accurate Reporting of Research

Authors must provide a truthful and accurate description of the research performed, including sufficient methodological details to enable reproducibility.

4.3 Data Transparency and Availability

Authors may be requested to provide underlying data for editorial review and should retain research data for a reasonable period after publication.

4.4 Multiple or Duplicate Publication

Manuscripts describing essentially the same research should not be submitted to more than one journal simultaneously. Redundant or duplicate publication is considered unethical unless clearly justified and disclosed.

4.5 Authorship Criteria

Authorship should be limited to individuals who have made substantial contributions to the study, including:

  • Conceptualization or study design
  • Data acquisition or analysis
  • Interpretation of results
  • Drafting or critical revision of the manuscript

All authors must approve the final manuscript prior to submission.

4.6 Disclosure of Conflicts of Interest

Authors must disclose any financial, institutional, or personal conflicts of interest that may influence the interpretation of their research.

4.7 Ethical Approval for Research

Studies involving human participants or animals must comply with recognized ethical standards and must have been approved by the appropriate ethics committee.

4.8 Clinical Trial Transparency

Clinical trials should be registered in publicly accessible registries, and reporting should follow recognized reporting guidelines such as CONSORT.

4.9 Image Integrity

Images should not be manipulated in ways that misrepresent data. Adjustments such as brightness or contrast are acceptable only if they do not obscure original information.

4.10 Correction of Errors

If authors discover significant errors in their published work, they must promptly notify the journal and cooperate in issuing corrections or retractions.

05

Responsibilities of Peer Reviewers

Peer review is a cornerstone of scholarly publishing and ensures the scientific quality of published research.

5.1 Contribution to Editorial Decisions

Reviewers assist editors in evaluating the validity, originality, and significance of manuscripts.

5.2 Confidentiality

Manuscripts received for review must be treated as confidential documents and must not be shared without permission.

5.3 Objectivity and Constructive Feedback

Reviews should be conducted objectively and should provide constructive criticism supported by clear arguments.

5.4 Conflict of Interest Disclosure

Reviewers must disclose any potential conflicts of interest and decline review if impartiality cannot be guaranteed.

5.5 Ethical Vigilance

Reviewers should identify possible ethical concerns, including plagiarism, duplicate publication, or data irregularities.

06

Research Misconduct

CEPIENTA® defines research misconduct to include, but not be limited to:

  • Plagiarism
  • Fabrication or falsification of data
  • Image manipulation
  • Duplicate publication
  • Undisclosed conflicts of interest
  • Improper authorship practices

Allegations of misconduct will be investigated following internationally accepted procedures and may involve communication with authors' institutions where necessary.

07

Corrections, Retractions & Expressions of Concern

To maintain the integrity of the scholarly record, CEPIENTA® may publish:

Corrections (Errata)

For minor errors that do not affect the overall conclusions of the work.

Corrigenda

Author-initiated corrections to address errors introduced by the authors.

Expressions of Concern

When serious issues are under investigation and a conclusion has not yet been reached.

Retractions

When findings are unreliable or have been published unethically and cannot stand in the scientific record.

08

Ethical Oversight & Compliance

CEPIENTA® journals adhere to internationally recognized ethical frameworks, including:

Committee on Publication Ethics (COPE) International Committee of Medical Journal Editors (ICMJE) CONSORT Guidelines for Clinical Trials PRISMA Reporting Standards STROBE Guidelines CARE Reporting Standards
09

Artificial Intelligence (AI) Use in Manuscripts

CEPIENTA® recognizes the growing use of artificial intelligence technologies in research and scholarly writing. To maintain transparency and accountability, the following principles apply.

9.1 Disclosure of AI Assistance

Authors must disclose the use of any AI-based tools used during manuscript preparation, including tools used for text generation or editing, image generation or modification, data analysis or interpretation, and language editing or translation. Disclosure should be made in the Methods section or an Acknowledgment statement.

9.2 AI Cannot Be an Author

Artificial intelligence tools cannot be listed as authors because authorship requires accountability, responsibility for the work, and the ability to respond to ethical inquiries.

9.3 Author Responsibility

Authors remain fully responsible for the accuracy of the manuscript, originality of content, avoidance of plagiarism, and verification of AI-generated information.

9.4 AI in Figures and Images

AI-generated images, graphs, or illustrations must be clearly identified and should not misrepresent research findings or manipulate scientific data.

9.5 Editorial Use of AI

Editors and reviewers may use AI tools for language improvement or technical evaluation but must ensure confidentiality and data protection of submitted manuscripts.

10

Data Sharing & Reproducibility Policy

Transparency in research data is essential for the reproducibility and credibility of scientific findings.

10.1 Data Availability

Authors are encouraged to make research data available through institutional repositories, public data repositories, or supplementary materials associated with the publication.

10.2 Data Availability Statements

All research articles should include a Data Availability Statement specifying where the data can be accessed, any restrictions on availability, and repository identifiers or accession numbers where applicable.

10.3 Reproducibility

Authors must provide sufficient methodological detail to allow other researchers to replicate the study, including protocols, software code, analytical methods, and raw or processed datasets where applicable.

10.4 Exceptions

Data sharing may be restricted when ethical or legal limitations exist, patient confidentiality must be protected, or proprietary or contractual agreements apply.

11

Preprint & Prior Publication Policy

CEPIENTA® supports the responsible dissemination of scientific knowledge and recognizes the role of preprint servers in accelerating research communication.

11.1 Preprint Submissions

Manuscripts previously posted on recognized preprint servers may be considered for publication provided that the preprint posting is disclosed at submission, the manuscript has not undergone formal peer review elsewhere, and the final published article includes appropriate acknowledgment of the preprint version.

11.2 Updating Preprints

After publication, authors should update the preprint record with a link to the final published article.

11.3 Prior Publication

Submission to CEPIENTA® journals or books implies that the manuscript has not been previously published in a peer-reviewed journal and is not currently under consideration elsewhere.

11.4 Conference Abstracts

Publication of preliminary findings as conference abstracts or posters does not constitute prior publication.

12

Appeals & Complaints Procedure

CEPIENTA® is committed to a fair, transparent, and accountable editorial process. Authors, reviewers, and readers may raise concerns regarding editorial decisions or publication ethics.

12.1 Appeals Against Editorial Decisions

Authors who believe their manuscript has been rejected unfairly may submit a formal appeal including a detailed explanation of the grounds for appeal, responses to reviewer comments, and supporting scientific evidence. Appeals are reviewed by the Editor-in-Chief and independent editorial advisors when necessary.

12.2 Complaints Regarding Editorial Process

Complaints may relate to peer review delays, ethical concerns, conflicts of interest, or allegations of editorial bias. All complaints will be investigated objectively and confidentially.

12.3 Handling Ethical Complaints

If complaints involve potential research misconduct, the journal will follow procedures recommended by the Committee on Publication Ethics. Investigations may involve correspondence with authors and reviewers, consultation with institutional authorities, and editorial board review.

12.4 Final Resolution

The decision of the Editor-in-Chief and publisher (CEPIENTA®) will be considered final after the completion of the investigation.

CEPIENTA® is dedicated to maintaining the highest standards of ethical publishing, transparency, and research integrity. All journals published by CEPIENTA® adhere to international ethical principles consistent with guidance from COPE and ICMJE, ensuring compliance with the expectations of global indexing services including PubMed, MEDLINE, Scopus, and Web of Science.